By Katherine Hamilton

Medline raised its full-year sales outlook as customer growth drove higher revenue in the first quarter.

The medical-surgical supplies maker on Wednesday posted a profit of $129 million, or 16 cents a share, in the quarter ended in late March, compared with $322 million a year earlier.

Stripping out one-time items, adjusted earnings per share were 33 cents, ahead of the 30 cents analysts polled by FactSet were forecasting.

Revenue rose 11% to $7.35 billion. Analysts surveyed by FactSet forecast revenue of $7.16 billion. The higher sales were driven by an increase in both new and existing customers.

Profit was lower because of increased costs from tariffs, as well as higher operating costs to support new customer growth and an employee bonus related to the company's initial public offering.

The Northfield, Ill., company began trading publicly in December 2025.

Medline raised its full-year outlook for organic sales growth to a range of 8.5% to 9.5%, up by 0.5 percentage points on both ends of the range. It maintained its guidance for adjusted earnings.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

May 06, 2026 07:46 ET (11:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.